
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast
00:00
Innovative Approaches in Managing Refractory DLBCL
This chapter delves into the management of primary refractory diffuse large B-cell lymphoma (DLBCL), advocating for CAR-T therapy in suitable patients. It highlights the role of bridging therapies, the leukapheresis process, and the necessity for meticulous post-infusion monitoring, while hinting at future discussions on relapse management and alternative therapies.
Transcript
Play full episode